Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen

Clinical Rheumatology

Volumn 20, Issue SUPPL. 1, 2001, Pages

  Evans, A M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Chirality; Cyclooxygenase; Enantiomers; Ibuprofen; Non steroidal anti inflammatory drug; Pharmacokinetics

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; DEXIBUPROFEN; FATTY ACID; FENOPROFEN; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; TRIACYLGLYCEROL;

ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; ENANTIOMER; ENZYME INHIBITION; HUMAN; LIPID METABOLISM; PAIN; PRIORITY JOURNAL; TOOTH PAIN;

EID: 0035194521     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03342662     Document Type: Article

References (32)

1. Commonly used chiral drugs: A survey
2. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
3. Clinical pharmacokinetics of ibuprofen. The first 30 years
4. Pharmacodynamics and pharmacokinetics of the profens: Enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen
5. Pharmacology and toxicology of ibuprofen
6. Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs
7. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs
8. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
9. The metabolic chiral inversion of 2-arylpropionic acids - A novel route with pharmacological consequences
10. Drug chirality: On the mechanism of R-aryl propionic acid class NSAIDs. Epimerization in humans and the clinical implications for the use of racemate
11. Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of the (-)-isomer
12. Mechanistic studies of the metabolic chiral inversion of R(-)-ibuprofen in humans
13. Variability in the disposition of ibuprofen enantiomers in osteoarthritis patients
14. Stereoselective metabolism of ibuprofen in humans: Administration of R-, S- and racemic ibuprofen
15. Stereoselective disposition of ibuprofen enantiomers in man
16. Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers
17. Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs
18. Pain-mediated altered absorption and metabolism of ibuprofen: An explanation for decreased serum enantiomer concentration after dental surgery
19. Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers
20. The stereoselective uptake of ibuprofen enantiomers into adipose tissue
21. Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs
22. Formation and reactivity of acyl glucuronides
23. Hepatic disposition of electrophilic acyl glucuronide conjugates
24. Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as detoxification mechanism?
25. Disposition and covalent binding of ibuprofen and its acyl glucuronide in the elderly
26. Enhanced analgesia and suppression of plasma beta-endorphin by the S(+)-isomer of ibuprofen
27. Evaluation of the efficacy and dose-response relationship of dexibuprofen (S(+)-ibuprofen) in patients with osteoarthritis of the hip and comparison with racemic ibuprofen using the WOMAX osteoarthritis index
28. Reevaluation of some double-blind, randomized studies of dexibuprofen (Seractil): A state-of-the-art overview
29. 'Overview on Clinical Data of Dexibuprofen'
30. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases
31. Inhibition of cyclooxygenase-1 and -2 by R(-)- and S(+)-ibuprofen
32. Kinetic basis for selective inhibition of cyclo-oxygenase